Covalent Modulation In Drug Discovery
WuXi AppTec is pleased to exhibit at Covalent Modulation in Drug Discovery, taking place October 7–8, 2026, in Cambridge, United Kingdom. With covalent approaches increasingly being used to address challenging therapeutic targets, successful programs require close integration between compound design, biological characterization, and optimization.
WuXi AppTec brings together chemistry and biology expertise to support covalent drug discovery from early hit identification through lead optimization and candidate selection. Our chemistry teams support covalent compound design, medicinal chemistry, SAR exploration, synthesis, and optimization of potency, selectivity, and physicochemical properties. In parallel, our biology teams provide biochemical and cellular assay development, target validation, hit confirmation, mechanism-of-action studies, target engagement assessment, and biological profiling to help researchers understand how covalent compounds interact with their targets and perform in relevant biological systems.
By integrating chemistry and biology within a coordinated discovery workflow, WuXi AppTec can help partners characterize covalent hits, understand binding and selectivity, establish meaningful structure–activity relationships, and efficiently advance promising compounds toward development. Additional DMPK, pharmacology, and preclinical capabilities can support programs as they progress beyond lead optimization.
Meet our Biology and Chemistry teams onsite in Cambridge to discuss how WuXi AppTec can support your covalent drug discovery program.
To schedule a dedicated meeting with our team, please fill out the form on the right.
Resource Links
WuXi AppTec Biology Services
Resource Type: Brochure
Research Chemistry Services
Resource Type: Brochure
